Obesity: Difference between revisions

Jump to navigation Jump to search

Obesity (view source)

Revision as of 15:24, 13 April 2024

92 bytes removed ,  7 months ago
no edit summary
No edit summary
No edit summary
Line 37: Line 37:
Kelly AS, Auerbach P, Barrientos-Perez M, et al. A Randomized, Controlled Trial of Liraglutide for Adolescents with Obesity. The New England journal of medicine. May 28 2020;382(22):2117-2128. doi:10.1056/NEJMoa1916038
Kelly AS, Auerbach P, Barrientos-Perez M, et al. A Randomized, Controlled Trial of Liraglutide for Adolescents with Obesity. The New England journal of medicine. May 28 2020;382(22):2117-2128. doi:10.1056/NEJMoa1916038


Weghuber D, Barrett T, Barrientos-Pérez M, et al. Once-Weekly Semaglutide in Adolescents with Obesity. The New England journal of medicine. Dec 15 2022;387(24):2245-2257. doi:10.1056/NEJMoa2208601
[https://www.nejm.org/doi/full/10.1056/NEJMoa2208601 Once-Weekly Semaglutide in Adolescents with Obesity]


[https://pubmed.ncbi.nlm.nih.gov/35441470/ STEP 1 Study Group. Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension]
[https://pubmed.ncbi.nlm.nih.gov/35441470/ STEP 1 Study Group. Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension]
Retrieved from "https://pedsanesthesia.net/wiki/index.php/Special:MobileDiff/4388"

Navigation menu